摘要
细菌疗法和纳米技术都在各种疾病的诊断和治疗应用中表现出了非凡的潜力。在个人健康的不同方面,这些微纳米系统的个体影响也进行了研究;但是,一个集成系统细菌纳米粒子(NP)很少被探索。未被开发的细菌NP结合可能是一个新的诊断和治疗像疟疾,肺结核和癌症的传染性疾病的工具。,当哺乳动物细胞遇到外来因素,如细菌时,因为他们的防御机制会表现出细胞摄入。在这些哺乳动物细胞的吞噬作用中,细菌破裂,被溶菌酶溶解。一种携带药物标签NP的细菌会被以同样的方式被吞噬,最终到达靶细胞,在癌组织快速连续的细胞分裂,导致血管缺陷,细胞互连不完全,缺氧区和肿瘤细胞异质数量的发展。这些肿瘤细胞中散乱的和发育不良的血管再生使常规化疗药物选择性定位肿瘤很困难。目前情况下,在癌症/肿瘤细胞的诊断和治疗中,可以预料现有的先进的纳米细菌疗法是为了进一步治疗癌症靶向药物的方法。本文着重对细菌疗法在诊断和治疗癌症中的潜在应用。
关键词: 细菌疗法,纳米粒子,药物输送,癌症、缺氧、肿瘤治疗。
Current Medicinal Chemistry
Title:Prospects of Bacteriotherapy with Nanotechnology in Nanoparticledrug Conjugation Approach for Cancer Therapy
Volume: 23 Issue: 14
Author(s): Ritu Raj, Surajit Das
Affiliation:
关键词: 细菌疗法,纳米粒子,药物输送,癌症、缺氧、肿瘤治疗。
摘要: Bacteriotherapy and nanotechnology have shown remarkable potential in diagnostic and therapeutic applications for various diseases. Individual impacts of these micro-nano systems over different aspects of human health are well studied; however, an integrated system of bacteria-nanoparticle (NP) conjugation is less explored. The untamed potential of bacteria-NP conjugation could be a new tool for diagnosis and treatment of invasive diseases like malaria, tuberculosis and cancer. Mammalian cells exhibit cytosis as their defense mechanism when they encounter foreign elements such as bacteria. In these mammalian cells, during phagocytosis, bacteria are ruptured and lysed by lysozymes. A bacterium carrying the drug-tagged NP would be engulfed in the same manner and ultimately reaches the target cells. Rapid and continuous cell divisions in the cancer tissues lead to defective vessels, underdeveloped cellcell interconnects, development of hypoxic areas and heterogeneous population of tumor cells. This unorganized and poorly developed angiogenesis in tumor cells makes it difficult for conventional chemotherapeutic drugs to localize the tumors selectively. In the present scenario of diagnosis and treatment of cancer/tumor cells, it could be expected that the existing bacteriotherapy with the advanced nanotechnology would be a way further in the targeted drug delivery for cancer therapy. This review emphasizes the potential applications of bacteriotherapy with nanotechnology for the diagnosis and treatment of cancer.
Export Options
About this article
Cite this article as:
Ritu Raj, Surajit Das , Prospects of Bacteriotherapy with Nanotechnology in Nanoparticledrug Conjugation Approach for Cancer Therapy, Current Medicinal Chemistry 2016; 23 (14) . https://dx.doi.org/10.2174/0929867323666160406120923
DOI https://dx.doi.org/10.2174/0929867323666160406120923 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
<i>In Silico</i> Vaccine Designing Targeting the Virulence Factors of mce Operons of <i>Mycobacterium avium</i> subsp. <i>Paratuberculosis</i>
Current Proteomics Deep Transfer Learning for COVID-19 Prediction: Case Study for Limited Data Problems
Current Medical Imaging Functional Polymeric Nano/Microparticles for Surface Adsorption and Delivery of Protein and DNA Vaccines
Current Drug Delivery Oxidative Stress in the Cochlea: An Update
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Medicinal Chemistry Editorial [Hot Topic: Nucleoside and Nucleotide Therapeutics: Recent Targets in Medicinal Chemistry (Guest Editor: Claire Simons)]
Current Topics in Medicinal Chemistry Trafficking Potentials of Unconventional T Cell Subsets
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Chemical Constituents from the Chinese Bryophytes and Their Reversal of Fungal Resistance
Current Organic Chemistry Transcriptional Regulation and Expression of CYP3A4 in Hepatocytes
Current Drug Metabolism The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets
Anti-Cancer Agents in Medicinal Chemistry Ascorbic Acid: An Old Player with a Broad Impact on Body Physiology Including Oxidative Stress Suppression and Immunomodulation: A Review
Mini-Reviews in Medicinal Chemistry Potential Therapeutic Agents from the Red Sea Organisms
Medicinal Chemistry Biologic and Novel Therapy of the Inflammatory Bowel Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Second-Line Antiretroviral Therapy for HIV-Infected Children in Resource Limited Settings
Current Pediatric Reviews Priority Strategies for Sustainable Fight Against HIV/AIDS in Low-Income Countries
Current HIV Research Targeting Folate Metabolism in the Human Malaria Parasite Plasmodium falciparum
Current Enzyme Inhibition Diversity of Bacteria and Bacterial Products as Antibiofilm and Antiquorum Sensing Drugs Against Pathogenic Bacteria
Current Drug Targets NMN/NaMN Adenylyltransferase (NMNAT) and NAD Kinase (NADK) Inhibitors: Chemistry and Potential Therapeutic Applications
Current Medicinal Chemistry Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome
Current Medicinal Chemistry Pediatric Immune Dysfunction and Health Risks Following Early-Life Immune Insult
Current Pediatric Reviews